产品: Osteopontin 抗体
货号: AF0227
描述: Rabbit polyclonal antibody to Osteopontin
应用: WB IHC IF/ICC
反应: Human, Mouse, Rat
预测: Bovine, Dog
分子量: 60kDa; 35kD(Calculated).
蛋白号: P10451
RRID: AB_2833402

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:3000, IF/ICC 1:100-1:500, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse,Rat
预测:
Bovine(88%), Dog(80%)
克隆:
Polyclonal
特异性:
Osteopontin Antibody detects endogenous levels of total Osteopontin.
RRID:
AB_2833402
引用格式: Affinity Biosciences Cat# AF0227, RRID:AB_2833402.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

BNSP; Bone sialoprotein 1; BSP I; BSPI; Early T lymphocyte activation 1; ETA 1; ETA1; MGC110940; Nephropontin; OPN; Osteopontin; osteopontin/immunoglobulin alpha 1 heavy chain constant region fusion protein; OSTP_HUMAN; PSEC0156; secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1); Secreted phosphoprotein 1; SPP 1; SPP-1; SPP1; SPP1/CALPHA1 fusion; Urinary stone protein; Uropontin;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
表达:
P10451 OSTP_HUMAN:

Bone. Found in plasma.

描述:
osteopontin Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction. Belongs to the osteopontin family. Ligand for integrin alpha-V/beta-3. 4 isoforms of the human protein are produced by alternative splicing.
序列:
MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSKSNESHDHMDDMDDEDDDDHVDSQDSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPVVPTVDTYDGRGDSVVYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNGAYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKANDESNEHSDVIDSQELSKVSREFHSHEFHSHEDMLVVDPKSKEEDKHLKFRISHELDSASSEVN

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Bovine
88
Dog
80
Sheep
78
Pig
73
Horse
67
Rabbit
33
Xenopus
0
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - P10451 作为底物

Site PTM Type Enzyme
S24 Phosphorylation
S26 Phosphorylation
S27 Phosphorylation
S49 O-Glycosylation
S49 Phosphorylation
S62 Phosphorylation
S63 Phosphorylation
T66 Phosphorylation
S76 Phosphorylation
S78 Phosphorylation
S81 Phosphorylation
S99 Phosphorylation
S102 Phosphorylation
S105 Phosphorylation
S108 Phosphorylation
S117 Phosphorylation
S120 Phosphorylation
S123 Phosphorylation
S126 Phosphorylation
S129 Phosphorylation
T134 O-Glycosylation
T134 Phosphorylation
T138 O-Glycosylation
T138 Phosphorylation
T143 O-Glycosylation
T143 Phosphorylation
T147 O-Glycosylation
T147 Phosphorylation
T152 O-Glycosylation
T152 Phosphorylation
Y165 Phosphorylation
T185 Phosphorylation
T190 Phosphorylation
S191 Phosphorylation
S195 Phosphorylation
Y202 Phosphorylation
S215 Phosphorylation
S219 Phosphorylation
S224 Phosphorylation
Y225 Phosphorylation
T227 Phosphorylation
S228 Phosphorylation
S234 Phosphorylation
T237 Phosphorylation
S239 Phosphorylation
S243 Phosphorylation
S254 Phosphorylation
S258 Phosphorylation
S263 Phosphorylation
S267 Phosphorylation
S270 Phosphorylation
S275 Phosphorylation
S280 Phosphorylation
S291 Phosphorylation
S303 Phosphorylation
S308 Phosphorylation
S310 Phosphorylation
S311 Phosphorylation

研究背景

功能:

Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction.

Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity.

翻译修饰:

Extensively phosphorylated by FAM20C in the extracellular medium at multiple sites within the S-x-E/pS motif.

O-glycosylated. Isoform 5 is GalNAc O-glycosylated at Thr-59 or Ser-62.

细胞定位:

Secreted.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
组织特异性:

Bone. Found in plasma.

亚基结构:

Ligand for integrin alpha-V/beta-3.

蛋白家族:

Belongs to the osteopontin family.

研究领域

· Cellular Processes > Cellular community - eukaryotes > Focal adhesion.   (View pathway)

· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Apelin signaling pathway.   (View pathway)

· Environmental Information Processing > Signaling molecules and interaction > ECM-receptor interaction.   (View pathway)

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Organismal Systems > Immune system > Toll-like receptor signaling pathway.   (View pathway)

文献引用

1). A Janus-Ros Healing System Promoting Infectious Bone Regeneration via Sono-Epigenetic Modulation. Advanced Materials (PubMed: 37855420) [IF=29.4]

Application: IF/ICC    Species: Rat    Sample: Bone

Figure 4. Biocompatibility and osteogenic differentiation ability of HN25. G) Immunofluorescence staining of ALP and OPN after culturing 14 d on different samples. Scale bar = 100 μm. H) Volcano plot showing differently expressed genes in MSCs from HN25 under US irradiation compared to the control.

2). Self-Adaptive MoO3−x Subnanometric Wires Incorporated Scaffolds for Osteosarcoma Therapy and Bone Regeneration. Advanced Functional Materials [IF=19.0]

3). Osteoblastic and anti-osteoclastic activities of strontium-substituted silicocarnotite ceramics: In vitro and in vivo studies. Bioactive Materials (PubMed: 32280833) [IF=18.9]

4). Fusion peptide engineered “statically-versatile” titanium implant simultaneously enhancing anti-infection, vascularization and osseointegration. Biomaterials (PubMed: 33069134) [IF=14.0]

5). On-demand storage and release of antimicrobial peptides using Pandora's box-like nanotubes gated with a bacterial infection-responsive polymer. Theranostics (PubMed: 31903109) [IF=12.4]

Application: WB    Species: Human    Sample: Human bone mesenchymal stem cells(hBMSCs)

Figure 5. In vitro biocompatibilities and osteogenic activities of the substrates. (A) CCK-8 assay of hBMSCs on the indicated surfaces after 1, 3 and 7 days of culture. * denotes p < 0.05 and ** denotes p < 0.01 compared to Ti-NTs, # denotes p < 0.05 compared to the corresponding control group without peptides. Error bars denote the standard deviations over quadruplicate measurements with separately implants. (B) Confocal fluorescence microscopy images of hBMSCs stained with vinculin, F-actin and DAPI after being cultured for 24 h. Scale bar, 50 μm. (C-F) qRT-PCR assay of osteogenic gene expression of (C) ALP, (D) RUNX-2, (E) COL1 and (F) OPN of hBMSCs after 7 and 14 days of culture. * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001 compared to Ti-NTs-P-A; # denotes p < 0.05, & denotes p < 0.01 and $ denotes p < 0.001 compared to the corresponding control group without peptides. All error bars denote the standard deviations over quadruplicate measurements with separately implants. (G) Immunofluorescence staining of hBMSCs cultured on Ti-NTs-P-A for 7 days (ALP and RUNX-2) and 14 days (OPN). The images were obtained by confocal fluorescence microscopy. Scale bar, 50 μm. (H) Western blotting of hBMSCs cultured on the substrates for 7 and 14 days. At each time point, left lane was Ti-NTs, middle lane was Ti-NTs-A and right lane was Ti-NTs-P-A. * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001 compared to Ti-NTs-P-A. Error bars denote the standard deviations over triplicate measurements with separately Western blotting results.

6). Biomimetic hydroxyapatite coating on the 3D-printed bioactive porous composite ceramic scaffolds promoted osteogenic differentiation via PI3K/AKT/mTOR signaling pathways and facilitated bone regeneration in vivo. Journal of Materials Science & Technology [IF=10.9]

7). Spontaneous formation of MXene-oxidized sono/chemo-dynamic sonosensitizer/nanocatalyst for antibacteria and bone-tissue regeneration. Journal of Nanobiotechnology (PubMed: 37316836) [IF=10.2]

Application: IF/ICC    Species: Rat    Sample: BMMSCs

Fig. 5 In vitro evaluation of C-T@Ti3C2 nanosheets for promoting osteogenesis. a Viability of rat bone marrow mesenchymal stem cells after incubation with different concentrations of C-T@Ti3C2 nanosheets (n = 3 for each group). b CLSM of AM/PI-stained rBMMSCs after various concentrations of C-T@Ti3C2 nanosheets. c CLSM images of the expression of BMP2, OCN, RUNX2 and OPN (at Day 14) in rBMMSCs after different treatments. A representative image of three replicates from each group is shown. d Relative mRNA levels of osteogenic genes (COL-I, BMP2, OPN and RUNX2). e Representative Western blots of total COL-I, OPN, BMP2, RUNX2 and β-actin after induction for 14 days in rBMMSCs. Data are presented as the mean ± SD, and statistical significance was calculated using the two-tailed t test

Application: WB    Species: Rat    Sample: BMMSCs

Fig. 5 In vitro evaluation of C-T@Ti3C2 nanosheets for promoting osteogenesis. a Viability of rat bone marrow mesenchymal stem cells after incubation with different concentrations of C-T@Ti3C2 nanosheets (n = 3 for each group). b CLSM of AM/PI-stained rBMMSCs after various concentrations of C-T@Ti3C2 nanosheets. c CLSM images of the expression of BMP2, OCN, RUNX2 and OPN (at Day 14) in rBMMSCs after different treatments. A representative image of three replicates from each group is shown. d Relative mRNA levels of osteogenic genes (COL-I, BMP2, OPN and RUNX2). e Representative Western blots of total COL-I, OPN, BMP2, RUNX2 and β-actin after induction for 14 days in rBMMSCs. Data are presented as the mean ± SD, and statistical significance was calculated using the two-tailed t test

8). A scaffold with zinc-whitlockite nanoparticles accelerates bone reconstruction by promoting bone differentiation and angiogenesis. Nano Research [IF=9.9]

9). Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway. PHYTOMEDICINE (PubMed: 33852977) [IF=7.9]

Application: IHC    Species: Human    Sample: HK-2 cells

Fig. 1. Effect of kaempferol on renal CaOx crystal deposition and tubular injury in vivo. Eligible mice were divided into five groups (n = 8). After a period of 10-day drug treatments, all mice were sacrificed on the 11 th day for the following tests. Pathological results were shown by the (a) images as well as (b-g) corresponding quantitative analysis through HE staining, Pizzolato staining, PAS staining, TUNEL staining, OPN and CD44 immunohistochemistry staining of paraffin embedded kidney sections. (h-j) Renal dysfunction was determined by serum levels of BUN, creatinine and NAGL among the five groups. (k) Group annotations were applied for all histograms. Data were expressed as the fold changes of experimental group to NC group or GA group, and were represented as means ± SD. * p < 0.05 vs. NC group; ** p < 0.05 as GA+Kae (25mg/kg) vs. GA group, GA + Kae (50 mg/kg) vs. GA group, and GA + Kae (25 mg/kg) vs. GA + Kae (50 mg/kg) group, respectively.

10). HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP. Frontiers in Immunology (PubMed: 35693826) [IF=7.3]

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.